UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 99

Sortiert nach

The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis

Alimentary pharmacology & therapeutics, 2010-11, Vol.32 (9), p.1207-1209

2010

Link zum Volltext

Verfügbarkeit prüfen

Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients

Alimentary pharmacology & therapeutics, 2012-09, Vol.36 (6), p.569-574

2012

Link zum Volltext

Verfügbarkeit prüfen

Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases

Clinical pharmacology and therapeutics, 2012-09, Vol.92 (3), p.306-320

2012

Link zum Volltext

Verfügbarkeit prüfen

Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival

Gastroenterology (New York, N.Y. 1943), 1998-06, Vol.114 (6), p.1161-1168

1998

Link zum Volltext

Verfügbarkeit prüfen

Systematic review: colitis associated with anti‐CTLA‐4 therapy

Alimentary pharmacology & therapeutics, 2015-08, Vol.42 (4), p.406-417

2015

Link zum Volltext

Verfügbarkeit prüfen

Systematic review with meta‐analysis: faecal diversion for management of perianal Crohn's disease

Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (7), p.783-792

2015

Link zum Volltext

Verfügbarkeit prüfen

Comparison of infliximab with adalimumab in 827 biologic‐naïve patients with Crohn's disease: a population‐based Danish cohort study

Alimentary pharmacology & therapeutics, 2018-03, Vol.47 (5), p.596-604

2018

Link zum Volltext

Verfügbarkeit prüfen

Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis

Digestive diseases and sciences, 2024-05, Vol.69 (5), p.1808-1825

2024

Link zum Volltext

Verfügbarkeit prüfen

The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review

Alimentary pharmacology & therapeutics, 2002-01, Vol.16 (1), p.51-60

2002

Link zum Volltext

Verfügbarkeit prüfen

Meta‐analysis: serological markers and the risk of acute and chronic pouchitis

Alimentary pharmacology & therapeutics, 2013-05, Vol.37 (9), p.867-875

2013

Link zum Volltext

Verfügbarkeit prüfen

Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

Alimentary pharmacology & therapeutics, 2004-01, Vol.19 (2), p.179

2004

Link zum Volltext

Verfügbarkeit prüfen

Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma – authors' reply

Alimentary pharmacology & therapeutics, 2016-01, Vol.43 (1), p.176-176

2016

Link zum Volltext

Verfügbarkeit prüfen

Letter: anti‐CTLA‐4‐associated colitis and inflammatory bowel disease pathogenesis – authors' reply

Alimentary pharmacology & therapeutics, 2015-10, Vol.42 (8), p.1032-1033

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study

Alimentary pharmacology & therapeutics, 2015-08, Vol.42 (3), p.330-342

2015

Link zum Volltext

Verfügbarkeit prüfen

Letter: comparative efficacy of biological therapy in patients with ulcerative colitis

Alimentary pharmacology & therapeutics, 2014-06, Vol.39 (12), p.1432-1433

2014

Link zum Volltext

Verfügbarkeit prüfen

Repifermin (keratinocyte growth factor‐2) for the treatment of active ulcerative colitis: a randomized, double‐blind, placebo‐controlled, dose‐escalation trial

Alimentary pharmacology & therapeutics, 2003-06, Vol.17 (11), p.1355-1364

2003

Link zum Volltext

Verfügbarkeit prüfen

Crohn's disease of the esophagus: Clinical features and outcomes

Inflammatory bowel diseases, 2001-05, Vol.7 (2), p.113-119

2001

Link zum Volltext

Verfügbarkeit prüfen

Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine

Gastroenterology (New York, N.Y. 1943), 2001-05, Vol.120 (6), p.1483-1484

2001

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of serologic disease markers in a population‐based cohort of patients with ulcerative colitis and Crohn's disease

Inflammatory bowel diseases, 2001-08, Vol.7 (3), p.192-201

2001

Link zum Volltext

Verfügbarkeit prüfen

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation

Hepatology (Baltimore, Md.), 1998-03, Vol.27 (3), p.685-690

1998

Link zum Volltext

Verfügbarkeit prüfen

Acute major gastrointestinal hemorrhage in inflammatory bowel disease

Gastrointestinal endoscopy, 1999-02, Vol.49 (2), p.153-157

1999

Link zum Volltext

Verfügbarkeit prüfen

Lymphoma risk in inflammatory bowel disease: Influences of referral bias and therapy

Gastroenterology (New York, N.Y. 1943), 2001-11, Vol.121 (5), p.1239-1242

2001

Link zum Volltext

Verfügbarkeit prüfen

Hunting for the owl's eye in acute severe colitis: the role of cytomegalovirus

Digestive and liver disease, 2004-12, Vol.36 (12), p.803-805

Loftus, E.V.

2004

Link zum Volltext

Verfügbarkeit prüfen

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis

Gastroenterology (New York, N.Y. 1943), 1996-02, Vol.110 (2), p.432-440

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

ThemaInflammatory Bowel Disease

ThemaRetrospective Studies

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(85)

Publikationsform

Artikel
(99)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(99)
Gastroenterology & Hepatology
(91)
Humans
(87)
Adult
(47)
Female
(46)
Male
(42)
Middle Aged
(37)
Aged
(28)
Biological And Medical Sciences
(28)
Medical Sciences
(28)
Crohn's Disease
(22)
Treatment Outcome
(21)
Gastroenterology. Liver. Pancreas. Abdomen
(20)
Pharmacology & Pharmacy
(18)
Adolescent
(17)
Crohn Disease - Drug Therapy
(17)
Other Diseases. Semiology
(17)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(17)
Risk Factors
(14)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus

The effects of itraconazole on inflammatory bowel disease activity in patients treated for histoplasmosis

Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients

Evolving Molecular Targets in the Treatment of Nonmalignant Gastrointestinal Diseases

Crohn's disease in Olmsted County, Minnesota, 1940–1993: Incidence, prevalence, and survival

Systematic review: colitis associated with anti‐CTLA‐4 therapy

Systematic review with meta‐analysis: faecal diversion for management of perianal Crohn's disease

Comparison of infliximab with adalimumab in 827 biologic‐naïve patients with Crohn's disease: a population‐based Danish cohort study

Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis

The epidemiology and natural history of Crohn’s disease in population‐based patient cohorts from North America: a systematic review

Meta‐analysis: serological markers and the risk of acute and chronic pouchitis

Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis

Letter: cytomegalovirus colitis in a patient treated with ipilimumab for metastatic melanoma – authors' reply

Letter: anti‐CTLA‐4‐associated colitis and inflammatory bowel disease pathogenesis – authors' reply

Clinical and demographic characteristics predictive of treatment outcomes for certolizumab pegol in moderate to severe Crohn's disease: analyses from the 7‐year PRECiSE 3 study

Letter: comparative efficacy of biological therapy in patients with ulcerative colitis

Repifermin (keratinocyte growth factor‐2) for the treatment of active ulcerative colitis: a randomized, double‐blind, placebo‐controlled, dose‐escalation trial

Crohn's disease of the esophagus: Clinical features and outcomes

Treatment of refractory microscopic colitis with azathioprine and 6-mercaptopurine

Evaluation of serologic disease markers in a population‐based cohort of patients with ulcerative colitis and Crohn's disease

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation

Acute major gastrointestinal hemorrhage in inflammatory bowel disease

Lymphoma risk in inflammatory bowel disease: Influences of referral bias and therapy

Hunting for the owl's eye in acute severe colitis: the role of cytomegalovirus

Risk of colorectal neoplasia in patients with primary sclerosing cholangitis

Aktive Filter

Suchergebnisse filtern